NO922304D0 - ELIMINATION OF ACTIVATED Lymphocytes - Google Patents

ELIMINATION OF ACTIVATED Lymphocytes

Info

Publication number
NO922304D0
NO922304D0 NO922304A NO922304A NO922304D0 NO 922304 D0 NO922304 D0 NO 922304D0 NO 922304 A NO922304 A NO 922304A NO 922304 A NO922304 A NO 922304A NO 922304 D0 NO922304 D0 NO 922304D0
Authority
NO
Norway
Prior art keywords
elimination
activated lymphocytes
activated
lymphocytes
octadecylglycero
Prior art date
Application number
NO922304A
Other languages
Norwegian (no)
Other versions
NO922304L (en
Inventor
Eberhard Wecker
Anneliese Schimpl
Rabbe Nordstroem
Original Assignee
Medmark Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medmark Pharma Gmbh filed Critical Medmark Pharma Gmbh
Publication of NO922304L publication Critical patent/NO922304L/en
Publication of NO922304D0 publication Critical patent/NO922304D0/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Luminescent Compositions (AREA)
  • Hydrogenated Pyridines (AREA)

Abstract

2-Methyl-1-octadecylglycero-(3)-phosphocholine is suitable for killing mammalian lymphocytes activated by antigens or mitogens.
NO922304A 1989-12-12 1992-06-11 ELIMINATION OF ACTIVATED Lymphocytes NO922304D0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3941009A DE3941009A1 (en) 1989-12-12 1989-12-12 ELIMINATION OF ACTIVATED LYMPHOCYTES
PCT/EP1990/002233 WO1991008746A1 (en) 1989-12-12 1990-12-11 Killing of activated lymphocytes

Publications (2)

Publication Number Publication Date
NO922304L NO922304L (en) 1992-06-11
NO922304D0 true NO922304D0 (en) 1992-06-11

Family

ID=6395316

Family Applications (1)

Application Number Title Priority Date Filing Date
NO922304A NO922304D0 (en) 1989-12-12 1992-06-11 ELIMINATION OF ACTIVATED Lymphocytes

Country Status (13)

Country Link
EP (1) EP0505414B1 (en)
JP (1) JPH05504132A (en)
AT (1) ATE102038T1 (en)
AU (1) AU638086B2 (en)
CA (1) CA2071520C (en)
DE (2) DE3941009A1 (en)
DK (1) DK0505414T3 (en)
ES (1) ES2062754T3 (en)
FI (1) FI922710A0 (en)
HU (1) HU217586B (en)
NO (1) NO922304D0 (en)
RU (1) RU2100025C1 (en)
WO (1) WO1991008746A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5517234A (en) * 1993-10-26 1996-05-14 Gerber Systems Corporation Automatic optical inspection system having a weighted transition database
DE19822509A1 (en) * 1998-05-19 1999-11-25 Medmark Pharma Gmbh Use of edelfosin for treatment of brain tumors, especially by oral administration
DE19829448A1 (en) * 1998-07-01 2000-10-12 Medmark Pharma Gmbh 1-Octadecyl-2-methyl-sn-glycero-3-phosphocholine (ET180CH3) for the treatment of human breast cancer
CA2634349A1 (en) * 2005-12-23 2007-06-28 Jado Technologies Gmbh Means and methods for the treatment and prevention of allergic diseases

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3918082A1 (en) * 1989-06-02 1991-01-24 Max Planck Gesellschaft AGENT FOR AUTOIMMUNE DISEASES

Also Published As

Publication number Publication date
ES2062754T3 (en) 1994-12-16
RU2100025C1 (en) 1997-12-27
HU9201976D0 (en) 1992-09-28
EP0505414B1 (en) 1994-03-02
FI922710A0 (en) 1992-06-11
DK0505414T3 (en) 1994-05-09
WO1991008746A1 (en) 1991-06-27
NO922304L (en) 1992-06-11
DE3941009A1 (en) 1991-06-13
ATE102038T1 (en) 1994-03-15
CA2071520C (en) 2002-10-01
HU217586B (en) 2000-02-28
JPH05504132A (en) 1993-07-01
AU6954391A (en) 1991-07-18
CA2071520A1 (en) 1991-06-13
HUT60927A (en) 1992-11-30
DE59004836D1 (en) 1994-04-07
AU638086B2 (en) 1993-06-17
EP0505414A1 (en) 1992-09-30

Similar Documents

Publication Publication Date Title
DK0435321T3 (en) New A-nor-steroid-3-carboxylic acid derivatives
EP0261224A4 (en) Synthetic htlv-iii peptides, compositions and uses thereof.
IT1100477B (en) PROCEDURE AND MEANS FOR THE MICROBIAL EXPRESSION OF POLYPERTIDS
FI20040479A (en) 3-aminopiperidine derivatives and methods for their preparation
IT7851783A0 (en) SYSTEM FOR THE APPLICATION OF HEADLESS RIVETS
FI833918A (en) -CARBOLINER, FOERFARANDE FOER DERAS FRAMSTAELLNING OCH DESSA INNEHAOLLANDE PHARMACEUTICAL PREPARATION
BG38334A3 (en) Method for preparing pyrolidinic derivatives
BG35328A3 (en) Method for preparing imidodisulphamidic derivatives
BG38163A3 (en) Method for preparing pyrimidones
NO922304L (en) ELIMINATION OF ACTIVATED Lymphocytes
AP8800109A0 (en) "Heterocyclic insecticides".
BG90414A (en) 2-AZABICYCLO (2,2,1)-HEPT-5-EN-2-ACETIC ACID AND ITS DERIVATIVES, METHOD OF PREPARATION AND THEIR APPLICATION
BG35749A3 (en) Method for preparing 20- dihydro- 20, 23- dideoxytilonolide
BG38338A3 (en) Method for preparing 6 alpha- methylhydrocortisonic derivatives
ES8502092A1 (en) Novel resolved keto compounds and process.
FR2454436A1 (en) SYNTHETIC POLYPEPTIDE WITH ANTIGENIC ACTIVITY AND PROCESS FOR THE PREPARATION THEREOF
NO792126L (en) CARBAZOLE DERIVATIVES.
BG38640A3 (en) Method for preparing n- arylsulphenyl- n- diaryloxy- phosphinylmethylglycinates
MY104318A (en) Novel thiopen compounds and their preparation
ATA109689A (en) BURNER PLATE OF AN ATMOSPHERIC BURNER
IT1245737B (en) Trialkylsilyl tetrafluoroethanephosphonates and process for the preparation thereof
SU1417444A1 (en) 2,4-Diphenyl-3 (4-acetoxy-4-methylhexin-2-yl) -3-azabicyclo [3.3.1] nonan-9-one exhibiting anti-inflammatory activity
FR2645445B1 (en) TECHNIQUE FOR THE ELIMINATION OF PYRALENE AND PYRALENE-OIL MIXTURES BY BIOLOGICAL WAY
BG35329A3 (en) Method for preparing n- phenyl- n- acetyl- 3- amino- oxazolidin- 2- ons
ATE87967T1 (en) COMPOSITION OF AN ADDITIONAL.